Skip to content

Advertisement

Aims and scope

The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.

Read more here.

Articles

Most accessed articles RSS

View all articles

About the society

New Content Item
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.

To learn more about the affiliation between Cardio-Oncology and ICOS, please see this blog on the BMC blog network.

Latest Tweets

Profile_Lipshultz

About the Editors

Steven Lipshultz, Editor-in-Chief

Steven Lipshultz is the Schotanus Family Professor and Chair of the Carman and Ann Adams Department of Pediatrics at the Wayne State University School of Medicine, as well as the Pediatrician-in-Chief at the Children’s Hospital of Michigan, the Pediatrics Specialist-in-Chief at the Detroit Medical Center, the President of University Pediatricians, and the Interim Director of the Children’s Research Center of Michigan. His primary research interests are in the pediatric cardiomyopathies, especially those of genetic/metabolic, toxic, or infections/inflammatory etiologies.

Profile_Carver

 

Joseph Carver, Deputy Editor

Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.

Profile_Minotti

 

Giorgio Minotti, Deputy Editor

Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.

Advertisement

Annual Journal Metrics

  • Speed
    31 days to first decision for reviewed manuscripts only
    29 days to first decision for all manuscripts
    73 days from submission to acceptance
    15 days from acceptance to publication

    Usage 
    46,539 Downloads
    44 Altmetric Mentions

Advertisement